Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effectiveness, Safety and Tolerability of RP-G28 in Subjects With Symptoms Associated With Lactose Intolerance

Trial Profile

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effectiveness, Safety and Tolerability of RP-G28 in Subjects With Symptoms Associated With Lactose Intolerance

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jan 2017

At a glance

  • Drugs RP G28 (Primary)
  • Indications Lactose intolerance
  • Focus Therapeutic Use
  • Sponsors Ritter Pharmaceuticals
  • Most Recent Events

    • 03 Jan 2017 According to a Ritter Pharmaceuticals media release, data from this trial published in Nutrition Journal Article 2013.
    • 03 Jan 2017 Results published in the Ritter Pharmaceuticals Media Release
    • 03 Jan 2017 According to a Ritter Pharmaceuticals media release, data from this trial published in the Proceedings of the National Academy of Science ("PNAS-Plus") PNAS 2017; Early Edition.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top